Get the app
US › Healthcare

AgomAb Therapeutics NV American Depositary Shares (AGMB)

US · Healthcare · Biotechnology

$12.08+5.87%
Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Net profit
$-11.7M
EPS
$-0.42

Key statistics

Market cap
$643.2M
Forward P/E
0.0
P/B
2.08
Book value
$2.64
EPS (TTM)
$-1.57
52-week high
$17.82
52-week low
$8.75
50-day MA
$13.38
200-day MA
$12.68

Analyst view

with an average price target of $37.67.

Shareholding

Insiders
5.90%
Institutions
53.64%

Largest institutional holders

FundStake
EQT Fund Management S.à r.l.10.44%
Sanofi5.65%
Redmile Group, LLC5.55%
Cormorant Asset Management, LLC5.01%
TCG Crossover Management, LLC4.17%
Federated Hermes Inc3.29%
Casdin Capital, LLC3.15%
Andera Partners3.12%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for AgomAb Therapeutics NV American Depositary Shares — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.